DISPERGIERBARE TABLETTENFORMULIERUNGEN ENTHALTEND DOLUTEGRAVIR

Patent europeic · EP4171572 · En vigur

Inscripziun en il register

Numer da publicaziun: EP4171572
Numer da la dumonda: EP21737779
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 23-06-2021
Publitgà: 03-05-2023
Concedì: 21-05-2025
La protecziun finescha il pli tard: 22-06-2041
Proxima taxa annuala scadenta: 30-06-2027
Classas IPC: A61K 31/5365 (2006.01)
A61K 9/20 (2006.01)
A61P 31/18 (2006.01)
A61K 9/28 (2006.01)
Prioritad: GB 202009684 25.06.2020
Dumonda PCT: PCT/IB2021/055533 23.06.2021
Publicaziun PCT: WO2021/260567 30.12.2021
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

01-07-2026
Next annual fee due on
Next annual fee due on
30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
02-04-2026
Midada
Published in Swissreg on 02.04.2026
01-07-2025
Next annual fee due on
Next annual fee due on
30.06.2025 → 30.06.2026
Published in Swissreg on 01.07.2025
21-05-2025
Concedì
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 21.05.2025

VIIV Healthcare Company

Corporation Service Company 251 Little Falls Drive, Wilmington, Delaware 19808, US